ABSTRACT
Introduction
Hepatitis B virus (HBV) is a common major endemic infection in Nigeria [1, 2] and its association with common major liver diseases is well established in our environment [3, 4] as in other parts of the world. HIV/AIDS continue to receive significant attention and a sizeable proportion of the health care budget because of the yet to be conquered pandemic. Previous studies in Nigeria have shown a significant hepatitis B and C virus co-infection with HIV infection [5, 6] . These studies however showed that hepatitis C, either as mono-infection or as coinfection with HIV infection is relatively low compared with HBV. Many of the antiretroviral drugs in current use are associated with hepatotoxicity among other side-effects. Hepatotoxicity of antiretroviral drugs especially co-infected patients with hepatitis viruses is a major concern, with increasing incidence of liver lidease [7] . Some studies have addressed the immunological (CD4 + ) and viral (HIV-RNA) responses in HIV/AIDS patients on combined antiretroviral therapy (CART). Micheloud et al. in their study among HCV-coinfected paediatric patients found no difference in clinical, immunological and viral response to CART over a six year period, save for increased transaminases among HCV coinfected [8] . A meta-analysis had shown that patients with HIV-HCV coinfection have less immune reconstitution, as determined by CD4 cell count after 48 weeks of CART, than patients with HIV monoinfection [9] suggesting some influence of hepatitis C on immunologic recovery in HIV infection. Clinical progression of HIV-1 disease after starting potent antiretroviral therapy is accelerated by concomitant infection with HCV. De Luca et al. concluded in their study that compared with patients without HCV coinfection, coinfected patients showed impaired CD4 + cell recovery, despite similar virologic response to HIV-1 therapy [10] . Since HBV is the most important co-infection among Nigerians, we embarked on a retrospective study of CART-naive HIV infected patients. The objective of the study was to determine the trend of changes in CD4 + counts, HIV-RNA load as well as biochemical, renal and liver function tests in response to CART.
Materials and Methods
The database of the PEPFAR clinic at the University College Hospital, Ibadan, Nigeria was searched between January 2006 and December 2007 to retrieve the presented data. The total number of patients on CART on the PEPFAR database at the time of data extraction was 4354 as at December 2007. A questionnaire was designed to extract the clinical data, liver function tests, CD4 + counts and HIV viral load as well as the antiretroviral combination of patients who were HBV-coinfected and compare with those who were mono infected with HIV. Hepatitis B surface antigen was detected from sera using commercially available 3rd generation ELISA technique (ABBOT Murex, Germany), while HIV antibody was initially detected by ELISA test followed by confirmation test using the Western blot hybridization. HIV-RNA quantification was by reverse transcriptase polymerase chain reaction (RT-PCR), with a lower detection rate of 400 copies/ml. All patients with HIV were tested for HBsAg at first visit, but HBeAg, anti-HBeAg and HBV-DNA were not determined. The results were noted at entry (baseline) before commencement of CART. HIV-RNA, CD4
+ counts, ALT, AST, urea and creatinine were then determined at six, twelve and eighteen months respectively. Only patients with HIV-1 and HIV-2 with detectable HIV-RNA and CD4 + count of ≤ 250 cells/ul were included in the study. Patients who were anti-HCV positive were excluded. Also excluded were those that had missing CD4, ALT and AST or were non-compliant with medication and those who were not able to do CD4 count at the time of entry due to equipment breakdown.
Statistical Methods
Quantitative variables were assessed for normality using visual inspection of box-plots and normal probability plots. The Chi square test was used to assess differences in frequencies for categorical variables. Levene's statistic was used to assess equality of variance between groups before independent two-sample tests for comparisons of means of Log 10 HIV viral load at baseline. Given the significant non-normality of CD4 count and liver function test results, a non-parametric two-sample (MannWhitney) test was performed to determine differences in their distribution between HBsAg status. Six hundred and sixteen cases with missen values (for follow up CD4 count/Viral load, AST/ALT) were excluded list wise automatically by the statistical software. The generalized linear model repeated measures analysis was performed to assess the effect of HBsAg status on treatment over time. Sex, education, baseline AST and ALT were adjusted for, and all statistical tests were carried out at the 5% significance level using SPSS 15.0. Ethical approval was obtained from the Joint University College Hospital, Ibadan/University of Ibadan Institutional Review Board.
Results

Socio-Demographic and Clinical Characteristics
Two thousand five hundred and sixty two patients who had sufficient retrievable data were included in the analysis. Of the 2562 patients, 354 (13.8%) were HBsAg positive. Majority (63.1%) were females. In terms of educational attainment, secondary (37.9%) and primary (29.7%) were the most common. A little above half (58.1%) were married. (Figure 1) . At 6 months, the median change was 143 cells/mm 3 and 148 cells/mm 3 for the negative and positive respectively. Although the meto adjust for some baseline characteristics that differs between the groups. Results from the model shows that neither of the covariates nor HBsAg status affects CD4 count recovery. HBV status, education, ALT and AST all did not affect CD4 count recovery ( The virological response was similar in the two groups at the various time points (Figure 2) . At 6 months, the generalized linear model was fitted for CD4 count change percentage of patients who had achieved viral suppression (HIV RNA level < 500 copies/mL) was 46.7% in the negative group and 43.3% in the positive group (p > 0.05). The percentages at 18 months were 71.0% and 68.8% for the negatives and positives respectively. Repeated measures analysis showed that HBsAg status did not have any effect on viral suppression over time ( Table 2 ).
AST, ALT, Urea and Creatinine
At baseline, ALT and AST levels were higher for the HBsAg positive patients (p < 0.05). The levels of these parameters at 6, 12 and 18 months are shown in Table 3 . at the time points, these parameters were similar for the two groups of patients. Majority of the monoinfected patients were on combivir and nevirapine, while the coinfected patients were mainly on truvada and nevirapine.
Discussion
This study has further shown a high HBV coinfection rate among our patient cohorts as previously noted by us and other authors in Africa [6, 11, 12] but higher than values obtained in the Western world with lower incidence of HBV [13, 14] . The preponderance of the female gender had been suggested to be due to the fact that women may be more sensitive to changes in their health and probably socioculturally conditioned to seek health care more than men [6] . The significantly higher coinfection among men compared with women in spite of a predominant female gender affected with HIV is likely a reflection of HBV prevalence among the general population which has been noted to be higher amongst men [15] . The lower prevalence of coinfection among the better educated individuals generally could be due to the level of awareness that may be associated with education and therefore behaviours and practices that may reduce HBV transmission [16] . It is however surprising that no difference in HBV prevalence was found across the different marital status. It would have been expected, arguably though, that divorcees and the unmarried would be more exposed to transmission of HBV sexually. This phenomenon might be confirming the well known fact that HBV transmission is mainly horizontal in childhood among Africans. Ola et al. however found out that HIV monoinfection is commoner among married people (70.4%), suggesting heterosexual transmission of HIV in our environment as previously documented [16] . It would appear that the immunological status of HBV coinfection and monoinfection is similar, as evidenced by the similar CD4 counts in HIV monoinfected and HIV-coinfected at the start of CART. Similar observations were made Idoko et al. in the Northern part of Nigeria [17] . It is evident from our study that CART has no influence on CD4 recovery regardless of HBV status with time and duration of therapy. Idoko et al. however found an association with Hepatitis B e antigen (HBeAg) and CD4 T-cell recovery and HIV-RNA clearance [17] . Apart from the higher baseline values of transaminases among HBV coinfected patients, no temporal difference was observed in the normalization of ALT, urea and creatinine among coinfected and monoinfected patients, suggesting that HBV status did not significantly influence the immunovirological response to CART, renal function and transaminase levels. The retrospective nature of this study and our inability to determine the date of acquisition of both HIV and HBV (acute or chronic), as well as unavailability of HBV DNA are some of the limitations of our study. The exclusion of subjects with missen data may also affect the result as it is unclear whether such cases were missing for reasons connected with the study outcome.
